Phathom Pharmaceuticals, Inc.
PHAT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783183
No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Phathom Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 94 | 1 | 87 | −6 |
| Shares | 30.2M | 115 | 28.2M | −1.97M (−6.5%) |
| Value | $334.3M | $1.00K | $316.6M | −$17.8M (−5.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 417,500 | $4.68M | 1.63% |
| Walleye Capital LLC | 145,870 | $1.64M | 0.04% |
| Gsa Capital Partners LLP | 18,517 | $208.0K | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 13,260 | $148.8K | 0.00% |
| AQR Capital Management LLC | 10,046 | $112.7K | 0.00% |
| Citadel Advisors LLC | 1,753 | $19.7K | 0.00% |
| U.S. Capital Wealth Advisors, LLC | 1,000 | $11.2K | 0.00% |
| Whittier Trust Co | 33 | $369 | 0.00% |
| Nisa Investment Advisors, LLC | 13 | $0 | 0.00% |
Sold out (15)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 2,414,897 | $26.8M |
| UBS Oconnor LLC | 154,093 | $1.71M |
| HRT Financial LP | 52,801 | $585.0K |
| Millennium Management LLC | 50,396 | $558.0K |
| Curi Capital | 45,000 | $499.0K |
| Balyasny Asset Management LLC | 18,532 | $205.0K |
| Cubist Systematic Strategies, LLC | 18,294 | $203.0K |
| Virtus ETF Advisers LLC | 16,847 | $187.0K |
| Trexquant Investment LP | 14,955 | $166.0K |
| D. E. Shaw & Co., Inc. | 14,477 | $160.0K |
| Ergoteles LLC | 14,378 | $159.0K |
| Manufacturers Life Insurance Company, The | 10,080 | $111.7K |
| Wells Fargo & Company | 407 | $5.00K |
| Point72 Hong Kong Ltd | 39 | $0 |
| Ellevest, Inc. | 12 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 115 | $1.00K |